102 related articles for article (PubMed ID: 26071105)
1. TRIM29 regulates the p63-mediated pathway in cervical cancer cells.
Masuda Y; Takahashi H; Hatakeyama S
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2296-305. PubMed ID: 26071105
[TBL] [Abstract][Full Text] [Related]
2. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185.
Qiu F; Xiong JP; Deng J; Xiang XJ
Int J Clin Exp Pathol; 2015; 8(5):5053-61. PubMed ID: 26191199
[TBL] [Abstract][Full Text] [Related]
4. Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.
Yanagi T; Watanabe M; Hata H; Kitamura S; Imafuku K; Yanagi H; Homma A; Wang L; Takahashi H; Shimizu H; Hatakeyama S
Cancer Res; 2018 Dec; 78(24):6795-6806. PubMed ID: 30389700
[TBL] [Abstract][Full Text] [Related]
5. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis.
Lee KB; Ye S; Park MH; Park BH; Lee JS; Kim SM
Cancer Lett; 2014 Oct; 353(1):124-32. PubMed ID: 25045846
[TBL] [Abstract][Full Text] [Related]
6. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.
Masuda Y; Takahashi H; Sato S; Tomomori-Sato C; Saraf A; Washburn MP; Florens L; Conaway RC; Conaway JW; Hatakeyama S
Nat Commun; 2015 Jun; 6():7299. PubMed ID: 26095369
[TBL] [Abstract][Full Text] [Related]
7. TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
Qiao HY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Yan J; Li C; Wang HQ
Cancer Lett; 2022 Mar; 529():85-99. PubMed ID: 34973391
[TBL] [Abstract][Full Text] [Related]
8. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
Rho SB; Park YG; Park K; Lee SH; Lee JH
FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
[TBL] [Abstract][Full Text] [Related]
9. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
10. A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.
Teissier S; Ben Khalifa Y; Mori M; Pautier P; Desaintes C; Thierry F
J Virol; 2007 Sep; 81(17):9368-76. PubMed ID: 17582001
[TBL] [Abstract][Full Text] [Related]
11. TRIM29 negatively regulates p53 via inhibition of Tip60.
Sho T; Tsukiyama T; Sato T; Kondo T; Cheng J; Saku T; Asaka M; Hatakeyama S
Biochim Biophys Acta; 2011 Jun; 1813(6):1245-53. PubMed ID: 21463657
[TBL] [Abstract][Full Text] [Related]
12. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.
Kosaka Y; Inoue H; Ohmachi T; Yokoe T; Matsumoto T; Mimori K; Tanaka F; Watanabe M; Mori M
Ann Surg Oncol; 2007 Sep; 14(9):2543-9. PubMed ID: 17597343
[TBL] [Abstract][Full Text] [Related]
13. TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.
Liu J; Welm B; Boucher KM; Ebbert MT; Bernard PS
Am J Pathol; 2012 Feb; 180(2):839-47. PubMed ID: 22138580
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of ΔΝp63α in cervical squamous cell carcinoma.
Zhou Y; Xu Q; Ling B; Xiao W; Liu P
Clin Invest Med; 2011 Jun; 34(3):E184-91. PubMed ID: 21631996
[TBL] [Abstract][Full Text] [Related]
15. TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer.
Kanno Y; Watanabe M; Kimura T; Nonomura K; Tanaka S; Hatakeyama S
Acta Histochem; 2014 Jun; 116(5):708-12. PubMed ID: 24485335
[TBL] [Abstract][Full Text] [Related]
16. The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.
Dükel M; Streitfeld WS; Tang TC; Backman LR; Ai L; May WS; Brown KD
J Biol Chem; 2016 Oct; 291(41):21541-21552. PubMed ID: 27535224
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
[TBL] [Abstract][Full Text] [Related]
18. LncRNA expression profile of ΔNp63α in cervical squamous cancers and its suppressive effects on LIF expression.
Qian L; Xu F; Wang X; Jiang M; Wang J; Song W; Wu D; Shen Z; Feng D; Ling B; Cheng Y; Xiao W; Shan G; Zhou Y
Cytokine; 2017 Aug; 96():114-122. PubMed ID: 28391028
[TBL] [Abstract][Full Text] [Related]
19. HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.
Zhang Z; Peng J; Li B; Wang Z; Wang H; Wang Y; Hong L
Cell Signal; 2023 Sep; 109():110747. PubMed ID: 37286120
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH
FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
